Ailawadhi, S., Bhutani, D., Hoering, A., Rosenthal, A., Ye, J. C., Kapoor, P., Usmani, S., Bhutani, M., Rajkumar, S. V., Gater, P., Orlowski, R. (2025). S2005: A phase II randomized study comparing ibrutinib and rituximab (IR) VS. venetoclax and rituximab (VR) in previously untreated waldenstrom's macroglobulinemia (WM) / lymphoplasmacytic lymphoma (LPL).. Blood. https://doi.org/10.1182/blood-2025-1840